TL;DR: Swallowing difficulties (dysphagia) affect between 35% and 82% of people with Parkinson’s disease, depending on how it is measured — with objective testing showing it is far more common than patients themselves report. Dysphagia in Parkinson’s is caused by the same neurological mechanisms that affect movement, voice, and muscle coordination. It typically progresses alongside the disease, but targeted strategies — including texture-modified diets, LSVT LOUD therapy, and levodopa timing — can meaningfully reduce aspiration risk and improve quality of life.
The most-cited systematic review on this topic — Kalf et al. (2012) — pooled 39 studies and found that objectively measured dysphagia affects approximately 4 out of 5 people with Parkinson’s disease (PD), while only about 1 in 3 spontaneously reports swallowing problems. 1
This gap between objective and subjective prevalence is clinically important: many patients with Parkinson’s disease have silent aspiration — food or liquid enters the airway without triggering a cough reflex, because PD also reduces the sensitivity of the protective cough response. Silent aspiration is a leading cause of aspiration pneumonia in this population.
A more recent meta-analysis (Mu et al. 2015) confirmed these figures and additionally found that dysphagia prevalence increases with disease severity, with Hoehn and Yahr stage 3 and above showing markedly higher rates. 2
A 2022 systematic review and meta-analysis in Frontiers in Neurology reported pooled prevalence of oropharyngeal dysphagia at approximately 35% by self-report and 82% by objective assessment in PD patients. 3
Swallowing is a complex motor sequence involving more than 30 muscles coordinated by brainstem and cortical circuits. In Parkinson’s disease, the dopaminergic depletion in the basal ganglia — the same pathology that causes tremor, rigidity, and bradykinesia — disrupts the timing and coordination of this sequence. Several mechanisms are at work:
The tongue, soft palate, and pharyngeal constrictors all show bradykinesia (slowed movement) and reduced amplitude in Parkinson’s disease. This manifests as:
The larynx must close the airway at precisely the right moment during swallowing. PD patients show delayed or incomplete laryngeal elevation and closure, increasing the risk that material enters the trachea before or after the swallow.
Many PD patients experience delays in triggering the swallowing reflex — they hold a bolus in the mouth for longer than normal before swallowing, increasing the risk of premature spillage into the airway.
Drooling in Parkinson’s disease is not caused by overproduction of saliva — it is caused by reduced frequency of spontaneous swallowing. PD patients swallow saliva less often, so it accumulates and spills. 4 This is often one of the first caregiver-noticed signs of oral motor dysfunction.
Parkinson’s pathology also affects the enteric nervous system, causing esophageal dysmotility — food moves through the esophagus more slowly and irregularly. This can cause the sensation of food “sticking” in the chest even after a safe oropharyngeal swallow.
The following symptoms warrant a referral to a speech therapist for formal swallowing assessment:
| Symptom | What it suggests |
|---|---|
| Coughing or choking during or after meals | Aspiration or pharyngeal residue |
| Wet or gurgly voice quality after eating/drinking | Pooling of material on vocal folds |
| Increased mealtime duration (>30 minutes for a normal meal) | Oral or pharyngeal slowing |
| Avoiding certain food textures (crunchy, dry, chunky) | Compensatory behaviour |
| Frequent chest infections / recurrent pneumonia | Silent aspiration over time |
| Unexplained weight loss | Inadequate intake due to dysphagia |
| Drooling | Reduced spontaneous swallowing frequency |
| Complaints that pills are hard to swallow | Pharyngeal or esophageal involvement |
Note: People with Parkinson’s disease often do not report dysphagia spontaneously. Caregivers should proactively ask about and observe mealtime behaviour, and raise concerns with the neurologist or GP promptly.
Swallowing difficulties in PD generally track with overall disease progression, but with an important asymmetry: oral phase problems (tongue control, bolus formation) tend to appear earlier and are more closely linked to motor severity, while pharyngeal and esophageal involvement often emerges in later stages. 5
Key progression patterns:
Before changing the diet, a speech therapist should assess swallowing function — ideally with an instrumental study (VFSS or FEES) in advanced cases, or at minimum a standardised bedside assessment (e.g., the Standardised Swallowing Assessment). This determines:
The IDDSI framework provides 8 levels (0–7) from thin liquids to regular food. For Parkinson’s disease patients:
| IDDSI Level | Best for |
|---|---|
| Level 6 — Soft & Bite-Sized | Mild oral difficulty; intact swallow reflex |
| Level 5 — Minced & Moist | Moderate oral/pharyngeal slowing |
| Level 4 — Puréed | Significant pharyngeal weakness; high residue risk |
| Level 3 — Liquidised | Severe dysphagia with high aspiration risk |
| Thickened liquids (L1–L3) | When thin fluids aspirate; match to speech therapist’s recommendation |
Positioning:
Pacing:
Food and drink choices:
An often-overlooked factor in Parkinson’s dysphagia management is the relationship between levodopa dosing and swallowing performance. Swallowing, like other motor functions in PD, responds to dopaminergic stimulation.
Research suggests that swallowing function is generally better during the “on” phase (when levodopa is active) than the “off” phase. Practical implications:
Lee Silverman Voice Treatment (LSVT) LOUD is the best-evidenced behavioural therapy for PD-related voice and speech problems. It uses intensive, high-effort phonation exercises to recalibrate the patient’s sense of “normal” loudness — people with PD tend to speak too softly without realising it.
Evidence also suggests LSVT LOUD has secondary benefits for swallowing — the intensive voicing exercises appear to improve pharyngoesophageal muscle function and may reduce aspiration. A study by El Sharkawi et al. (2002) found significant reductions in swallowing impairment following LSVT LOUD treatment. 7
LSVT LOUD is delivered by a certified speech therapist over 4 weeks (4 sessions per week, 1 hour each). It requires active patient effort and cognitive engagement, so it is best suited to patients in earlier disease stages. Maintenance exercises are required after the intensive phase.
In Hong Kong, LSVT LOUD certified therapists can be found through the Hong Kong Speech and Hearing Association (HKSHA) or through hospital-based SLP departments.
Dysphagia in Parkinson’s disease is a significant risk factor for aspiration pneumonia — the most common cause of death in PD. Key prevention strategies beyond diet modification include:
| Mistake | Better approach |
|---|---|
| Waiting for the patient to complain | Proactively assess; most patients don’t report symptoms |
| Assuming dysphagia is constant | Swallowing varies with motor fluctuations — time meals to “on” periods |
| Using the same texture for all foods and liquids | Solids and liquids often require different management strategies |
| Stopping LSVT LOUD after therapy ends | Maintenance exercises are essential; gains decline without practice |
| Ignoring oral hygiene | Oral bacteria in aspirated material substantially increase pneumonia risk |
This article summarises published research and clinical guidelines on dysphagia in Parkinson’s disease. It is intended for caregivers and healthcare students. For clinical management of an individual patient, consult a registered speech therapist and the treating neurologist. This page is not medical advice.
Last updated: 2026-04-13 · License: CC BY 4.0 · Maintained by Editorial Team — a Hong Kong social enterprise producing IDDSI-compliant care food for people living with dysphagia. This page is educational only; see About for our clinical partners and social mission.
Kalf JG, de Swart BJ, Bloem BR, Munneke M. “Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis.” Parkinsonism & Related Disorders. 2012;18(4):311-315. — https://pubmed.ncbi.nlm.nih.gov/22137459/ ↩
Mu L, et al. “Parkinson disease and the pharynx.” Handbook of Clinical Neurology. 2015. Referenced in: Dysphagia in Parkinson Disease — PMC — https://pubmed.ncbi.nlm.nih.gov/26590572/ ↩
Frontiers in Neurology — “The prevalence and associated factors of dysphagia in Parkinson’s disease: a systematic review and meta-analysis” (2022) — https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1000527/full ↩
Parkinson’s Foundation — Speech & Swallowing Issues — https://www.parkinson.org/understanding-parkinsons/non-movement-symptoms/speech-swallowing ↩
PMC — “Oro-Pharyngeal Dysphagia in Parkinson’s Disease and Related Movement Disorders” — https://pmc.ncbi.nlm.nih.gov/articles/PMC6763715/ ↩
Consensus on the treatment of dysphagia in Parkinson’s disease. Journal of the Neurological Sciences. 2021. — https://www.jns-journal.com/article/S0022-510X(21)02704-0/fulltext ↩
El Sharkawi A, et al. “Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.” J Neurol Neurosurg Psychiatry. 2002;72(1):31-36. Cited in: PMC — Dysphagia in Parkinson Disease Part I — https://pmc.ncbi.nlm.nih.gov/articles/PMC10441627/ ↩